MIT's Dr. Mark Bear on what FRAXA means to his lab

Mark Bear, PhD, Picower Professor of Neuroscience at the Massachusetts Institute of Technology (MIT), studies synaptic function in Fragile X syndrome and other autism spectrum disorders. He has worked with FRAXA since 1999 and is a member of FRAXA’s Scientific Advisory Board.

With FRAXA funding, Dr. Bear has helped open new doors in Fragile X research. For example, Dr. Kim Huber started her Fragile X studies as a FRAXA Postdoctoral Fellow in Dr. Bear's lab. She now runs her own lab at University of Texas Southwestern Medical Center, Dallas. Her lab is one of the 3 Centers for Collaborative Research in Fragile X that was funded by with $35 million from NIH in 2014. Dr. Bear is grateful for the support of FRAXA donors who help him leverage larger investments in Fragile X research.

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

To learn more about FRAXA's Fragile X Syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit FRAXA.org

Let's Connect: